[Effect of anticoagulants of the 4-hydroxycoumarin derivative group on aminotransferase activity in vitro and in vivo].
D015110:4-Hydroxycoumarins / Q000494:pharmacology* / Q000627:therapeutic use; D000410:Alanine Transaminase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D046508:Culture Techniques; D004791:Enzyme Inhibitors; D006801:Humans; D007189:Indans / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D011817:Rabbits
D015110:4-Hydroxycoumarins; D004791:Enzyme Inhibitors; D007189:Indans; C001445:1,3-indandione; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Wpływ leków przeciwzakrzepowych z grupy pochodnych 4-hydroksykumaryny na aktywność aminotransferaz w badaniach in vitro in in vivo.